Linagliptin Metformin HCI Tablets are a combination medication used to treat type 2 diabetes. The tablets contain both linagliptin and metformin hydrochloride which work together to lower blood sugar levels. Linagliptin belongs to a class of drugs known as DPP-4 inhibitors and metformin belongs to a class of drugs known as biguanides. The combination of these drugs helps to control blood sugar levels by increasing insulin secretion and reducing glucose production in the liver. These tablets are meant for oral consumption and the dosage guidelines are as suggested by a healthcare professional. The tablets come in a physical form of capsules and are packaged in a box containing 10*10 tablets. It is advised to store these tablets in a cool and dry place. These general medicines are manufactured in India.
Strength | 2.5 mg/500 mg |
Pack Size | 1*10 Tablet |
Pack Type | Strip |
Prescription/Non Prescription | Prescription |
Shelf Life | 24 Months |
Usage | To Treat Type 2 Diabetes |
Price: